Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
Royal Canin has announced the launch of its Christmas promotion through which practice clients will be rewarded with activity balls for cats and leashpods for dogs.
The stocking fillers will be distributed to practices along with promotional materials such as posters and shelf wobblers, to encourage clients to buy Royal Canin Veterinary Care Nutrition (VCN) pet food.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers who purchase any 1.5kg bag of feline VCN or any 3.5kg bag of canine VCN from their vet will receive a cat activity ball or a leashpod to thank them for their custom and support.
"For those who don't know what a leashpod is, it's a fantastic dog lead handle to help you carry all those essential items needed for walking a dog. It has an integrated bag dispenser, its own scented mini bin for storing smelly used bags and two secure pockets for treats, keys, money or your mobile phone."
For more information about the Christmas promotion, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
A new animal welfare report by the PDSA has revealed that millions of pets are more aggressive, overweight and misunderstood than ever due to fundamental gaps in pet owners' animal welfare knowledge.
The PDSA Animal Wellbeing (PAW) report, which captures the views of pet owners, the veterinary profession and children, reveals that 1.3 million dogs across the UK are displaying problem behaviour. It also highlights the consequences of an obesity epidemic affecting 18.5 million dogs, cats and rabbits, and draws attention to the 11.2 million pets not registered with a vet and therefore at risk of disease due to not being vaccinated or neutered.
The BVA is urging veterinary surgeons and nurses to read the report which identifies where owners are misinformed or unaware and highlights areas that everyone can work on with their clients to help achieve better wellbeing for pets.
Peter Jones, President of the BVA, said: "This is another excellent report from the PDSA offering real insight into clients' motivations. Understanding what drives owners' attitudes, as well as helping them to understand key health and welfare issues, should help us to clarify misconceptions in the consulting room and hopefully change behaviour at home.
"On the positive side, with pet obesity ever rising it is good to see that there is a slight increase in the proportion of owners starting to recognise obesity in their pets. This is, no doubt, in part due to the tireless work of charities like the PDSA and the veterinary profession as a whole.
"Sadly, despite most owners' awareness of the ill effect that bad nutrition has on their pet this has not led to them cutting out pet treats. The fact that few can identify a healthy body shape shows that much remains to be done.
"The section on preventive healthcare remains worrying with many owners seemingly not believing in the concepts of microchipping, neutering and vaccination. Vets have a real responsibility to help communicate these issues to the pet owning public for the benefit of both clients and their animals.
"The report very clearly identifies where owners are misinformed or unaware and highlights areas that vets in practice can work on with their clients to help achieve better wellbeing for pets.
"The report is very clearly laid out and well worth a read. We would encourage all vets to take a look and identify any new educational resources to promote in the practice, in newsletters and on websites in addition to the ones they already make available to clients. The AWF leaflets, the PDSA's own website, and the Education Alliance are all good starting points."
Click here for the report.
The RCVS has announced a number of senior staff changes.
Gordon Hockey has been ratified by Council as Head of Legal Services and Registrar. This is a new role created when the post of Registrar and Secretary was split into two: Chief Executive and Secretary; and Head of Legal Services and Registrar.
Gordon, who was previously Assistant Registrar/Head of Professional Conduct, and then Acting Registrar, will have oversight responsibility for registration and professional conduct.
At the same time, Eleanor Ferguson, formerly Acting Head of Professional Conduct, has been confirmed in the position.
The post of Head of Registration has been made redundant, with a new role of Customer Experience Manager created to ensure that the customer (public and profession) journey improves across the organisation. This position will also report into Gordon Hockey.
There have been other changes on the Senior Team at the College. The post of Head of Corporate Services that had been vacant since the departure of Richard Holford last December will not be filled, and Head of Finance Corrie McCann has been promoted to the new role of Head of Operations, which will incorporate finance, corporate services (IT, mailing, reception) and facilities.
Two other posts have been made redundant: Special Projects Manager and RCVS Charitable Trust Director. A new post of Executive Director for the Trust will be developed, with a view to taking the Trust through a full strategic review.
Chief Executive Nick Stace said: "I believe that an engaged and well-purposed team of staff, with a focus on customer service and driving improvements, lies at the heart of any successful organisation. These changes will enable the College to move into the next stage of its development towards becoming a first-rate regulator."
The changes will mean that the Senior Team is reduced from 11 people to seven, being the Chief Executive plus Heads of Legal Services, Operations, Human Resources, Education, Veterinary Nursing and Communications.
Following a new study published in the journal Emerging Infectious Diseases, the World Small Animal Veterinary Association's One Health Committee has called for a co-ordinated global infectious disease monitoring system to be established for veterinarians who work in small companion animal practice worldwide.
The study, led by Michael Day, Professor of Veterinary Pathology in the School of Veterinary Sciences at the University of Bristol and Chair of the WSAVA's One Health Committee, lists the key zoonotic diseases of cats and dogs.
It recommends that the knowledge gained through surveillance would permit more effective global control of small companion animal zoonoses and reduce the risks associated with the human-animal relationship.
Professor Day said: "It is well recognised that most of the major new diseases of mankind will have an animal origin and that dogs and cats are a potential source of such emerging diseases.
"The number of small companion animals is particularly significant. For example there are an estimated eight to ten million dogs living in up to 31 per cent of UK homes and in the USA, 72 million dogs in 37 per cent of homes. The benefits of pet ownership on human health, well-being and development are unquestionable but, as they have moved from the barn, to the house, to the bedroom, the potential for disease spread to humans increases. Control of diseases among dogs and cats is a good way to prevent spread to humans.
"In human, livestock and wildlife heath there are already programmes of active surveillance for infectious disease underway to monitor the global distribution and movement of key infectious agents. For example, the WHO monitors human influenza virus infection through a network of 111 centres in 83 countries. In contrast, there is no such monitoring for the infections that may be transmitted between small companion animals and man. Meanwhile, canine rabies virus infection, one of the diseases listed in the paper, is estimated to kill a minimum of 55,000 people in Africa and Asia each year.
"The development of such a scheme would require the significant political will, scientific application and financial support that could be achieved through a public-private partnership. The aim of our position paper in Emerging Infectious Diseases is to initiate stakeholder discussions with that end goal in mind."
Kruuse has announced that it is now the exclusive veterinary distributor in the UK, Europe, Australia and New Zealand for Nurtured Pets' Anti-LickStrip pet plaster, a natural hypo-allergenic adhesive plaster that deters licking, biting and chewing.
Anti-LickStrip's plaster is made with active ingredients including cayenne pepper, oregano, lemon powder and peppermint that acts as a deterrent to the animal when sniffed, licked or bitten. The veterinary range of Anti-Lick products will be co-branded under the Kruuse 'Buster' brand as: Buster Anti-LickStrip (sizes: small, medium and large) Buster Anti-LickStrip Pro and Buster Anti-LickStrip Pro C.
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This agreement further expands Kruuse's small animal product portfolio with its customer in Scandinavia, mainland Europe and the UK; increasing the already extensive range of animal tamper deterrents available to the veterinary practitioner."
Lisa Huntsman, President, Lauren Manufacturing & Nurtured Pets said: "This exciting partnership will further expand our products presence within the veterinary industry expanding our delivery of focused health and wellness products to customers, using Kruuse's strong relationships within veterinary practices."
Nominations are now being sought for candidates to stand in the Royal College of Veterinary Surgeons Council and Veterinary Nurse Council (VN Council) elections. The deadline for nominations is 5pm on 31 January 2013.
Nick Stace, RCVS Chief Executive said: "Last year, a record number of veterinary surgeons showed by seeking a seat on RCVS Council that they were willing to help regulate their profession. The RCVS needs the efforts of willing vets and VNs to ensure that their professions continue to be well regulated. If you've thought about standing 'someday' - why not make someday now?"
There are six seats due to be filled on RCVS Council, and two on VN Council. Those elected will take their seats on RCVS Day next July, to serve four-year terms. Council members will be expected to spend at least six to eight days a year attending Council and Committee meetings, working parties and subcommittees (for which a loss-of-earnings allowance is available).
Each candidate needs to find two proposers; any veterinary surgeon or veterinary nurse (who is not presently on either Council) may propose one candidate for RCVS or VN Council respectively.
Nomination forms, full instructions and guidance notes are available from www.rcvs.org.uk/rcvscouncil13 and www.rcvs.org.uk/vncouncil13.
For the first time this year the RCVS will organise a webinar-style hustings event for RCVS Council candidates during the election period. This will offer candidates the opportunity to outline his or her manifesto verbally in a live event, with an audio-only recording. It will not be compulsory for candidates to take part, although it is hoped that the event will enable candidates to make their points in a way that will engage a broader range of voters than the paper manifestos alone.
The RCVS is reminding all veterinary nurses intending to remain on its List/Register of Veterinary Nurses that it needs to receive any outstanding retention fees on or before 31 December.
The College says it will be writing to all VNs whose fees have not yet been received, and will not remove anyone from the List/Register whose fees have been paid and cleared by 31 December.
You can pay your fees online using the individual log-in numbers on the fee letters sent in October.
If you have mislaid your log-in number, you can email webadmin@rcvs.org.uk, including your full name, date of birth, address on the Register/List, and badge number (engraved on the back of your VN badge). Payments can also be made by bank transfer, using the details from the fee letter. If paying by cheque, please write your name and Register/List number on the back. Cheques need to be received by the RCVS before 21 December, and the payment to have cleared by 31 December. The retention fee for veterinary nurses is due annually by 1 November.
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
Rimifin (carprofen), an NSAID marketed by Vetoquinol, has been given a new flavour to help increase compliance.
Robert Simpson, Product Manager for Rimifin said: "Pet owner compliance and involvement in chronic pain situations is critical to ensuring effective long term treatment. Ease of administration is also very important in this setting. The addition of this flavouring to this popular and cost effective NSAID will help to ensure that administration to the patient is as easy as possible for pet owners and vets."
To find out more about Rimifin please contact your Vetoquinol Territory Manager or call 01280 825424.
Ceva Animal Health has announced the launch of Cardalis for the treatment of canine heart failure caused by degenerative valvular heart disease.
Cardalis contains what the company says is a unique combination of benazepril and spironolactone in one tablet which provides "dual blockade" of the RAAS system.
Benazepril reduces the production of angiotensin II, which causes narrowing of the blood vessels, while spironolactone blocks the harmful effects of aldosterone, which include cardiovascular remodelling and fibrosis.
Cardalis tablets are small, beef flavoured and designed to be administered once a day with food. Each pot contains 30 tablets and there are three sizes available. Ceva says it should be given as part of standard heart failure therapy as soon as clinical signs, such as exercise intolerance, coughing or dyspnoea, appear.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "Through our clinical studies, it has been found that dogs receiving benazepril and spironolactone (compared with benazepril alone) have a better quality of life and, at any one time, are three times less likely to die from heart failure.
"We have also assessed 101 dogs in a field study that were prescribed Cardalis for three months, followed by separate benazepril and spironolactone tablets for two weeks. In the study, 97 per cent of dog owners found Cardalis easier to administer than the two separate tablets and 89 per cent of vets found Cardalis easier to prescribe."
For further information about Cardalis, or to receive marketing materials for the product (which include a waiting room poster and client information booklets), visit www.ceva.com.uk, or contact the practice support team on 01494 781510.
The badger culls planned to take place in West Somerset and West Gloucestershire this year have been postponed until 2013.
The postponement came at the request of The National Farmers Union (NFU), following new survey results which revealed higher than anticipated badger numbers in the two pilot areas (4,300 in West Somerset and 3,600 in West Gloucestershire ).
The NFU informed Defra that in light of these new figures they could not be confident of removing the required minimum 70% of the badgers in the two pilot areas this autumn.
Defra agreed to postpone the pilot culls until summer 2013 to allow farmers to continue their preparations and have the best possible chance of carrying out the cull effectively.
Environment Secretary Owen Paterson said: "Despite a greatly increased effort over the last few days and weeks, the farmers delivering this policy have concluded that they cannot be confident that it will be possible to remove enough badgers based on these higher numbers and considering the lateness of the season. It would be wrong to go ahead if those on the ground cannot be confident of removing at least 70% of the populations. Today I have received a letter from the President of the NFU, on behalf of the companies coordinating the culls, explaining why they do not feel they can go ahead this year and requesting that they be postponed until next summer. In these circumstances, it is the right thing to do and, as the people who have to deliver this policy on the ground and work within the science, I respect their decision.
"The Government is determined to tackle bovine TB by all the means available to us. Now, in the next few months, we will ensure that the pilot culls can be implemented effectively, in the best possible conditions, with the right resources. Having looked at all the evidence over many years, I am utterly convinced that badger control is the right thing to do, and indeed the higher than expected badger numbers only serve to underline the need for urgent action. I remain fully committed to working with the farming industry to ensure that the pilot culls can be delivered effectively, safely and humanely next summer."
The Government and NFU say they will now continue to plan so that the pilots can go ahead in Summer 2013.
Ceva Animal Health has launched Cystease Advanced, a new urinary tract support supplement for cats.
The new product, which contains N-acetyl glucosamine, L-tryptophan and Hyaluronic Acid, is described as an elaboration on the original product, Cystease S.
Ceva says Cystease Advanced has been designed to help support the bladder lining while also reducing stress-related behaviour in cats.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "It is well documented that stress can adversely affect the integrity of the bladder lining. There are many factors that cause stress in cats, for example inter-cat conflict, moving house, new arrivals to the home environment and car travel, to name just a few.
"Our new product has been developed to address both conditions; it contains N-acetyl glucosamine and Hyaluronic Acid which are key components of the GAG lining, whereas L-tryptophan has been proven to reduce stress-related behaviour in cats."
Cystease Advanced is taken orally and is available in pots of 30 and 300 tablets.
Ceva recommends that Cystease Advanced is used with Feliway, the company's appeasing pheromone for cats.
For further details please contact the customer support team on 01494 781510.
Petplan has announced that nominations are now open for its 14th annual Veterinary Awards.
The awards recognise members of the veterinary community who have gone above and beyond in their daily role.
According to the company, one in three pets make an unexpected trip to the vet each year, making vets the unofficial 4th emergency service. A quarter of pet owners consider their vet a good friend with 42% on first name terms. 98% of Petplan customers have said that they trust their vet; with many saying that they are more trustworthy than police officers - coming second only to doctors.
Petplan's Head of Marketing, Isabella Von Mesterhazy said: "At Petplan, we hear from our customers every day about the exceptional service veterinary staff have given to pets in their care. The Veterinary Awards are an opportunity for Petplan to show our support to members of this profession and thank these hard-working individuals on a national scale. We want to encourage pet owners across the UK to nominate their veterinary stars this year to show their appreciation for all their tireless effort to keep the nations pets fit and healthy."
To make nominate a vet, vet nurse, vet practice and other members of the veterinary team visit www.petplan.co.uk/vetawards before 31st January 2013. The winners will be announced at the ceremony held in Birmingham on 4th April 2013.
Kruuse has announced that it is to become the exclusive veterinary distributor in Europe for Kit4Cat, a globally patented hydrophobic sand for veterinary use.
Kit4Cat is a biodegradable sand with a natural non-toxic urine repelling coating which allows veterinary surgeons, veterinary nurses and cat owners to collect a urine sample for urinalysis without resorting to more invasive procedures. Kit4Cat is put in the cat's normal litter tray, whereupon it repels rather than absorbs the urine, allowing it to be collected with a pipette.
Andrew Groom, Managing Director, Kruuse UK Ltd., said: "This exciting agreement and product range further expands Kruuse's small animal product portfolio with its customers in Scandinavia, mainland Europe and the UK; increasing the already extensive range of feline products available to the veterinary practitioner."
Daniel Levitt, BA, MSM, CEO, Co-Founder & Board Member of Coastline Global, the makers of Kit4Cat, said: "This agreement will further expand our products presence within the veterinary industry, using Kruuse's strong relationships within veterinary practices, to promote less stressful ways of urine test collection prior to diagnosis and treatment of cats."
Bayer Animal Health has produced a take home prescription guide to encourage pet owners to remain compliant with its antimicrobial, Veraflox (pradofloxacin).
The leaflet contains prescription details together with a treatment record and next appointment reminder. Group Product Manager Tracey Dawson said: "There is also a FAQ (frequently asked questions) section explaining why compliance is so important."
Bayer says the leaflet has been developed to help vets and VNs ensure pet owners are encouraged to be responsible with prescribed medicines. Tracey added: "The guide is designed to reinforce the information given by the prescribing vet, and answer further questions owners might have on arrival home or during the treatment."
Bayer highlights that Veraflox's mode of action helps reduce the potential for the development of resistant bacteria¹, but only if it is used correctly. Tracey said: "Although it might seem to be easy for pet owners to adhere to the advice given with prescribed medicines, especially with the more palatable options now available, it is very important that we help preserve the efficacy of the fluoroquinolone class by continuing to encourage strict client compliance through correct dosing, and finishing the course of antibiotics prescribed."
For further information, contact your Bayer Territory Manager or call Bayer Animal Health on 01635 563000.
Reference
Wetzstein HG. Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance. Antimicrob Agents Chemother. 2005;49(10): 4166-4173
4,661 veterinary surgeons voted, the highest turnout seen in ten years. 1,329 veterinary nurses voted, the highest ever number.
Veterinary surgeons voted incumbents Christopher Gray, Peter Jinman, Bradley Viner, Christopher Tufnell, and Jeremy Davies back onto the RCVS Council. However, the highest number of votes was given to Thomas Witte, who will be new to Council when he takes his seat in July. Veterinary nurses voted similarly by returning Andrea Jeffery to VN Council, whilst giving to Amy Robinson, another newcomer, the largest number of votes.
According to the College, turnout in both elections has increased markedly on last year in both absolute and proportional terms. Votes were cast by 4,661 veterinary surgeons (18.8%) and 1,329 veterinary nurses (12.5%), compared to 3,625 (15.1%) and 743 (7.5%), respectively, in 2012.
Gordon Hockey, RCVS Registrar said: "We're delighted with the increase in turnout. It's difficult to pinpoint the reasons for the increase, but hopefully, it's because increasing numbers of vets and nurses are feeling more engaged with the College. We have also undertaken extra communications activities this year, such as the 'hustings', which we hope have helped."
The Council election 'hustings' was a new venture this year, with RCVS Council candidates able to select three questions, submitted by voters, to answer in a live webinar run by The Webinar Vet.
Veterinary surgeons and VNs could cast their votes by post, online, or by text. The majority of vets voting chose to cast postal votes (3,247), as did the majority of VNs (1,055). Whilst voting online was used by 1,330 veterinary surgeons, only 227 VNs chose it as a means of voting. Voting by text was used by only 84 veterinary surgeons and 47 VNs.
The successful candidates will take up or resume their seats at RCVS Day on 5 July.
The full results of the two elections are as follows:
RCVS Council electionWITTE, Thomas Hermann - 2,251 (Elected)GRAY, Christopher John - 1,974 (Elected)JINMAN, Peter Charles - 1,949 (Elected)VINER, Bradley Phillip - 1,927 (Elected)TUFNELL, Christopher Wynne - 1,883 (Elected)DAVIES, Jeremy Vincent - 1,830 (Elected)STURGESS, Christopher Paul - 1,809 CONNELL, Niall Thomas - 1,596 ROBINSON, Peter Bayley - 1,366 ELLIS, Robert Nigel Ward - 1,302 GRANT, Lewis George - 832 TORGERSON, Paul Robert - 824 LONSDALE, Thomas - 337 Twenty-two votes in the RCVS Council election were found to be invalid.VN Council election
ROBINSON, Amy - 725 (Elected)JEFFERY, Andrea Karen - 607 (Elected)BADGER, Susan Frances - 459TOTTEY, Helen Wendy 332 One vote in the VN Council election was found to be invalid.The 2013 RCVS and VN Council elections were run on behalf of the RCVS by Electoral Reform Services.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
Bayer Animal Health, maker of Tracer microchips, has produced a new video in which Emma Milne and Petlog Executive Celia Walsom consider the implications for practices of the change in the law which will make it compulsory for all dogs to be microchipped from April 2016.
The 15-minute video considers various issues, such as:
The College of Animal Welfare has opened a business school at its training and education centre in Chord Business Park in Godmanchester.
CAW Business School provides accountancy courses accredited by the Association of Accounting Technicians (AAT) and leadership and management courses accredited by the Institute of Leadership and Management (ILM).
Leslie Heaton Smith, Director at The College of Animal Welfare, said: "The opening of our Business School is a new development in a long line of achievements and marks an exciting new venture. Whilst our focus has always been towards developing technical animal and veterinary related knowledge and skills to make significant improvements in animal welfare and veterinary care, we also recognise that quality of care is also highly dependent on the management and leadership of those controlling and investing the organisation's often scarce resources. Thus in order to provide high quality welfare to animals entrusted into their care, organisations need to be able to employ people with such skills".
The leadership and management courses are already underway and can be studied entirely online, or online with study weekends.
The College says the majority of AAT courses will start in September 2013, however an 8 week Level 2 Certificate in Bookkeeping course starts at the beginning of June. The College is also an AAT approved exam centre, meaning that students can sit their exams whilst at college.
For further information, call the College on 01480 422060 and speak to one of the Business School tutors. Alternatively, visit www.caw.ac.uk or book a place on the next open day on Wednesday 22 May from 9am-12pm or 6-9pm.
The American Kennel Club Canine Health Foundation has awarded Dr. Bruce Smith, director of the Auburn University Research Initiative in Cancer, a two-year grant totaling $118,848 to test a new therapy for treating bone cancer in dogs.
According to the University, the research could one day be broadened to include many other kinds of cancer - and possibly cancer in people.
The treatment consists of a virus normally used as a hepatitis vaccine in dogs that has been modified to only make copies of itself inside bone cancer cells. The virus ruptures the cancer cells, releasing thousands of copies of the virus from the tumor cells, killing them.
Dr. Smith said: "By using this approach, we turn the cancer cell into a 'factory' that produces more virus. You could say that we help the cancer cell become an agent of its own death."
Bone cancer, or osteosarcoma, accounts for around 5% of tumours in dogs. More than 90% of dogs with this tumour have had tumour cells migrate into their lungs, creating what are known as micrometastases, at the time of diagnosis.
Dr. Smith said: "This therapy attacks those metastases and will hopefully eliminate them or make them more sensitive to chemotherapy."
The Auburn University Research Initiative in Cancer, or AURIC, was founded in 2012 to accelerate translation of cancer innovation from the laboratory to the clinic. AURIC embodies "One Medicine" - the concept that sees human and animal health as a single field where discoveries in one species advance health in both species.
Fitzpatrick Referrals has launched a new sports medicine and rehabilitation centre for dogs at its referral centre in Surrey.
Fitzpatrick Referrals has been running a dedicated rehabilitation centre since the practice opened at Eashing in 2007. It has now extended the offering to include sports medicine clinics and osteoarthritis clinics, creating what it claims is the largest centre of its kind in the country.
Building work has now been completed at the centre and Fitzpatrick Referrals has appointed David Prydie MRCVS, a small animal rehabilitation expert, to head up the centre.
Speaking about the launch of the new service, Noel Fitzpatrick, Managing Director of Fitzpatrick Referrals said: "At Fitzpatrick Referrals, we believe that appropriate rehabilitation is integral to the success of orthopaedic and neuro-surgical intervention and fundamental in promoting pain free functional quality of life.
"Traditionally, the rehabilitation centre has been geared towards treating post-op patients. While the new centre will continue to treat animals which have been referred to Fitzpatrick Referrals for surgical procedures, helping to restore function, reduce pain and speed up the recovery process, we will now offer new dedicated Sports Medicine and Osteoarthritis clinics, of which there are currently only a handful in the UK. This will provide referring practitioners and clients with a new range of options for dealing with sports injuries and the on-going management of Osteoarthritis.
"For the first time, minimally invasive arthroscopic investigation and advanced diagnostic imaging with MRI and CT will be available side-by-side with a team of clinicians who truly understand the unique anatomy, physiology and exercise demands of working and sports dogs and who adopt an integrated approach to achieving maximum mobility for dogs of all ages. We intend that the new centre will create a new standard of integrated care for the active performance or pet dog because we will match function with form and intention with action. Every plan will be tailor made for the individual with sincere attention to the very special environment and demands of the sporting dog. I'm extraordinarily excited about this new horizon."
David Prydie added: "We expect to see cases where there are specific injuries which the canine athlete is prone to and which require specialist knowledge to identify and treat. Our goal is to help the dogs return to their performance event as soon as possible. We will also be offering advice on training regimes for the various activities. The centre will offer a new osteoarthritis clinic, treating osteoarthritis in all ages of dog using a multimodal approach such as weight management, exercise regimes, physiotherapy techniques and use of tools such as the therapeutic laser. There is a wealth of experience already present within the practice and I will be working with Noel and the other surgeons to develop our offering in sports injury management and also with Professor Stuart Carmichael in the development of osteoarthritis management schemes."
The practice will celebrate the launch of the new centre with its first festival for pets, 'Dogfest', built around the theme of the 'Active Dog'. The festival will take place on 10th and 11th of August and will feature a number of agility and flyball events, canine sports medicine lectures delivered by world experts, a range of tents and stalls, 'Have a Go' agility sessions, an agility display by former Fitzpatrick patients who have returned to compete in the agility circuit, a 'Meet the Fitzpatrick Heroes' display and a special '999' display by the Sussex Police Dogs on both days.
For information on the new Fitzpatrick Sports Medicine and Rehabilitation Centre services and to discuss referrals, contact the reception team on 01483 423 761.
Virbac is offering its customers a discount on subscriptions to Vet Care Consult, an interactive veterinary medicine and anatomy tool designed to improve client understanding and aid compliance.
Vet Care Consult, designed by MediProductions with advice from veterinary specialists, uses more than 600 3D graphics, animations, videos and other imagery to help veterinary staff explain diagnoses and to discuss therapeutic options.
The veterinary surgeon or nurse selects the target species, then the relevant organ or system. A range of animations and videos are then offered to help explain their recommendation. The tool includes the option to email owners a link to a specific animation or video so that they can discuss the recommended treatment with family later. It can be used on a PC or tablet and is also available as an iPhone app.
A single user subscription normally costs £41 per month or £410 per annum.
Chris Geddes MRCVS, Senior Product Manager at Virbac, said: "Gone are the days of scribbling diagrams on scraps of paper and whiteboards or pointing to a model of a stifle that has seen better days!
"Vet Care Consult harnesses the latest technology to help the veterinary team communicate more effectively with clients, helping them to understand their pets' health and wellness issues. Better communication leads to improved compliance which, in turn, helps to strengthen the vital bond between a practice and its clients."
For more information, contact your Virbac Territory Manager.
Petlog has released the results of research to discover what dog owners know about microchipping and the upcoming change in legislation which will make chipping compulsory from 2016.
The survey was conducted amongst 1000 people in May. 46% of those that own dogs were unaware that microchipping is to become compulsory. Of the 54% that did know about the new legislation, only about 20% knew that it comes into force in 2016.
The survey revealed a surprising lack of understanding about how microchips work. 14.85% of dog owners - which would amount to more than 1M people in the UK - thought a microchip acted as a GPS device.
Half of all pet owners did not know whether the contact details on their pet's microchip record are up to date.
Petlog conducted the survey as part of National Microchipping Month which takes place this June. The awareness campaign has been running for 10 years now, to raise the profile of pet microchipping and its benefits and also to educate pet owners about how it works, the need to keep contact details up to date and how to make the most from a database.
Celia Walsom, Petlog Executive said: "Raising awareness about microchipping was our first priority when we began National Microchipping Month in 2004, but now we want to ensure pet owners fully understand exactly how the microchip works, that they need to keep their contact details up to date and of course are aware of what is happening in regards to legislation.
"Microchipping is the most popular form of permanent identification, and has reunited hundreds of thousands of pets and owners in the UK since it was introduced here over twenty years ago, and yet pet owners do not seem to fully understand how the microchip works and why it is so important to keep their contact details up to date.
"Worryingly the research found that around 12% of pet owners wrongly believe that the microchip acts as some sort of GPS device, or can stop a pet from wandering a certain distance. It is important that people understand how a microchip works so that they know how to make the most of it.
"We also need pet owners to understand that they need to keep their contact details up to date as it becomes a lot harder and slower, if possible at all, to reunite pets when contact details become outdated."
Talking about Petlog's annual campaign, Animal Welfare Minister, Lord de Mauley said: "I fully support National Microchipping Month. Campaigns like this are important in showing dog owners that microchipping is a safe, easy and quick procedure that can save owners a lot of potential heartbreak if their dogs stray. With Dogs Trust, Battersea Dogs and Cats Home, and Blue Cross all offering free microchipping, there is no excuse for dog owners not to chip their dogs before the April 2016 deadline."
To find out more about National Microchipping Month and events that are taking place in your area, visit www.nationalmicrochippingmonth.org.uk.